istock-504614550_brauns-1

brauns / iStockphoto.com

29 June 2017GeneticsMarisa Moura Momoli

CRISPR in Brazil: dealing with breakthrough technology

In 2012, the world was introduced to one of the greatest scientific discoveries in recent years: CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

USPTO clarifies AI's role in patent eligibility

Novo Nordisk’s uphill battle in the counterfeit weight loss craze

Unified Patent Court: The cases, the numbers and what the future holds

Second chances: Brazil’s bid to revitalise the country’s healthcare system

Why the US non-competes ban has riled Big Pharma

Life sciences cases at the UPC will surely rise, but is the court prepared?

Biopharma sues USPTO over rejected shock therapy patent